Rituximab

Landis S, Murray T, Bolden S, et al. Cancer statistics. Cancer J Clin 1999; 49: 8–31
Article CAS Google Scholar
Aisenberg A. Coherent view of non-Hodgkin’s lymphoma. J. Clin Oncol 1995; 13: 2656–75
PubMed CAS Google Scholar
Horning SJ. Natural history of and therapy for the indolent non-Hodgkin’s lymphomas. Semin Oncol 1993 Oct; 20 (Suppl. 5): 75–88
PubMed CAS Google Scholar
Nadler L, Stashenko P, Hardy R, et al. Serotherapy of a patient with a monoclonal antibody directed against a human lymphoma-associated antigen. Cancer Res 1980; 40: 3147–54
PubMed CAS Google Scholar
Demidem A, Lam T, Alas S, et al. Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs. Cancer Biother Radiopharm 1997; 12: 177–86
Article PubMed CAS Google Scholar
Czuczman MS, Grillo-López AJ, White CA, et al. Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy. J Clin Oncol 1999 Jan; 17: 268–76
PubMed CAS Google Scholar

Author information

Authors

Myron S. Czuczman
View author publications
You can also search for this author in PubMed Google Scholar

Czuczman, M.S. Rituximab. Drugs 58, 89 (1999). https://doi.org/10.2165/00003495-199958010-00010

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.